Safety and efficacy of perforator flap breast reconstruction with combined intraabdominal procedures

Annals of Plastic Surgery
William J CaseyPaul M Magtibay

Abstract

Genetic testing for BRCA mutations has led to greater needs for breast reconstruction and prophylactic gynecologic procedures. A retrospective review of all perforator flap breast reconstructions was performed over 5 years. A total of 316 flaps were performed on 232 patients. Nineteen patients had an intraabdominal procedure at the time of their breast reconstruction, including 8 unilateral and 11 bilateral reconstructions (22 flaps). The concomitant procedures incurred an additional mean operative time of 61 minutes. One arterial thrombosis occurred leading to a single flap failure (1/30, 3.3%). No significant differences were noted in complication rates between the combined group and those who did not have a simultaneous procedure (anastomotic complications 3.3% vs. 7.7%; failure rate 3.3% vs. 3.1%; abdominal wound 10.5% vs. 15%; fat necrosis 10% vs. 12.2%). The coordinated effort allowing simultaneous intraabdominal procedures and perforator flap breast reconstruction affords effective reconstruction for those requiring additional procedures without an increase in postoperative complication rates.

References

Jun 1, 1989·Plastic and Reconstructive Surgery·T R HesterJ Cukic
Apr 10, 1995·American Journal of Medical Genetics·M J SellerG S Tint
May 15, 1997·The New England Journal of Medicine·J P StruewingM A Tucker
Jan 14, 1999·The New England Journal of Medicine·L C HartmannR B Jenkins
Aug 5, 1999·Journal of the National Cancer Institute·UNKNOWN Breast Cancer Linkage Consortium
Feb 9, 2000·JAMA : the Journal of the American Medical Association·D SchragJ C Weeks
Nov 8, 2001·Journal of the National Cancer Institute·L C HartmannR B Jenkins
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lauren ScheuerKenneth Offit
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hanne Meijers-HeijboerJan G M Klijn
Dec 10, 2003·Archives of Surgery·Jeffrey N WeitzelCarey A Cullinane
Feb 26, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy R RebbeckBarbara L Weber
Apr 15, 2004·Plastic and Reconstructive Surgery·Paul S GillRobert J Allen
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly MetcalfeSteven A Narod
Feb 3, 2006·Cancer Research·Gillian MitchellDouglas F Easton
Feb 18, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sining ChenGiovanni Parmigiani
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lori J PierceBarbara L Weber
Jul 4, 2006·Plastic and Reconstructive Surgery·W Grant StevensElliot M Hirsch
Dec 7, 2006·Journal of the National Cancer Institute·Harvey A RischSteven A Narod
Jan 16, 2007·Current Opinion in Obstetrics & Gynecology·Susan M Domchek, Timothy R Rebbeck
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sining Chen, Giovanni Parmigiani
Apr 2, 2009·Plastic and Reconstructive Surgery·William J CaseyBarbara A Pockaj

❮ Previous
Next ❯

Citations

Sep 2, 2016·Annals of Surgical Oncology·Irene T MaBarbara A Pockaj
Sep 21, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jayeeta Banerjee, Marit Nilsen-Hamilton
Nov 26, 2019·Clinical Obstetrics and Gynecology·Casey L Swanson, Jamie N Bakkum-Gamez
Sep 22, 2018·Journal of Minimally Invasive Gynecology·Mariam M AlHilli, Zahraa Al-Hilli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.